Blood marker may forecast liver survival in biliary atresia
NCT ID NCT05848310
First seen Apr 02, 2026 · Last updated Apr 29, 2026 · Updated 4 times
Summary
This study looks at whether a substance in the blood called FGF19, measured before surgery, can help predict how well children with biliary atresia will do after their operation. Researchers will follow 200 children for one year to see if FGF19 levels are linked to liver function and the need for a liver transplant. The goal is to find a simple way to identify which children may have better or worse outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BILIARY ATRESIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Children's Hospital of Fudan University
RECRUITINGShanghai, Shanghai Municipality, 201100, China
Conditions
Explore the condition pages connected to this study.